Barclays PLC Acrivon Therapeutics, Inc. Transaction History

Barclays PLC

  • $327 Billion
  • Q2 2024

A detailed history of Barclays PLC transactions in Acrivon Therapeutics, Inc. stock. As of the latest transaction made, Barclays PLC holds 22,033 shares of ACRV stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
22,033
Previous 21,324 3.32%
Holding current value
$0
Previous $153,000 16.99%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
N/A
709 Added 3.32%
22,033 $127,000
Q1 2024

May 15, 2024
SELL
N/A
-3,160 Reduced 12.91%
21,324 $153,000
Q4 2023

Feb 15, 2024
BUY
N/A
10,384 Added 73.65%
24,484 $121,000
Q3 2023

Nov 07, 2023
SELL
N/A
-163 Reduced 1.14%
14,100 $135,000
Q2 2023

Aug 03, 2023
SELL
N/A
-2,720 Reduced 16.02%
14,263 $184,000
Q1 2023

May 04, 2023
BUY
N/A
12,841 Added 310.02%
16,983 $215,000
Q4 2022

Feb 13, 2023
BUY
N/A
4,142 New
4,142 $47,000

Others Institutions Holding ACRV

# of Institutions
53
Shares Held
23.7M
Call Options Held
0
Put Options Held
0
View Full List

About Acrivon Therapeutics, Inc.

ACRV Quotes by TradingView
  • Ticker ACRV
More about ACRV
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email